BlackRock Institutional Trust’s PDL BioPharma, Inc. PDLI Stock Holding History

BlackRock Institutional Trust’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.3M	Buy	5,819,729 +718,707	+14%	+$2.01M	﹤0.01%	2286
2016 Q3	$17.1M	Sell	5,101,022 -72,002	-1%	-$229K	﹤0.01%	1996
2016 Q2	$16.2M	Buy	5,173,024 +250,137	+5%	+$834K	﹤0.01%	1981
2016 Q1	$16.4M	Buy	4,922,887 +238,586	+5%	+$744K	﹤0.01%	1947
2015 Q4	$16.6M	Buy	4,684,301 +109,337	+2%	+$458K	﹤0.01%	1989
2015 Q3	$23M	Sell	4,574,964 -40,578	-0.9%	-$233K	﹤0.01%	1742
2015 Q2	$29.7M	Sell	4,615,542 -45,884	-1%	-$307K	﹤0.01%	1639
2015 Q1	$32.8M	Buy	4,661,426 +100,109	+2%	+$725K	0.01%	1599
2014 Q4	$35.2M	Sell	4,561,317 -3,507	-0.1%	-$27.8K	0.01%	1529
2014 Q3	$34.1M	Sell	4,564,824 -47,359	-1%	-$440K	0.01%	1524
2014 Q2	$44.6M	Sell	4,612,183 -40,926	-0.9%	-$365K	0.01%	1390
2014 Q1	$38.7M	Buy	4,653,109 +269,073	+6%	+$2.31M	0.01%	1480
2013 Q4	$37M	Buy	4,384,036 +15,215	+0.3%	+$128K	0.01%	1487
2013 Q3	$34.8M	Sell	4,368,821 -87,039	-2%	-$700K	0.01%	1444
2013 Q2	$34.4M	Buy	+4,455,860	New	+$34.7M	0.01%	1403

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Institutional Trust's PDLI Position: Q4 2016 in Review

BlackRock Institutional Trust increased its PDL BioPharma, Inc. (PDLI) stake by 14% in Q4 2016, buying an estimated $2.01M and bringing the position to 5,819,729 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2286.

BlackRock Institutional Trust first reported a position in PDLI in Q2 2013 and has held it in 15 quarters since. The position peaked at $44.6M in Q2 2014. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

BlackRock Institutional Trust held 5,819,729 shares of PDL BioPharma, Inc. worth $12.3M as of Q4 2016.
BlackRock Institutional Trust bought 718,707 PDL BioPharma, Inc. shares in Q4 2016, an estimated $2.01M.
PDL BioPharma, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2286 holding.
BlackRock Institutional Trust first reported a position in PDL BioPharma, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's PDL BioPharma, Inc. position peaked at $44.6M in Q2 2014.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.